Document:

Registration Rights Agreement

 Exhibit 10.97 
  
 REGISTRATION RIGHTS AGREEMENT 
  

This Registration Rights Agreement (this “Agreement”) is made and entered into as of December 6, 2005, by and between Path 1 Network
Technologies Inc., a Delaware corporation (the “Company”), and Laurus Master Fund, Ltd. (the “Purchaser”). 
  
 This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, by and between the Purchaser and the Company (as
amended, modified or supplemented from time to time, the “Securities Purchase Agreement”), and pursuant to the Note and the Warrants referred to therein. 
  
 The Company and the Purchaser hereby agree as follows: 
  
 1. Definitions. Capitalized terms used and not otherwise defined herein that are defined in the Securities Purchase
Agreement shall have the meanings given such terms in the Securities Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings: 
  
 “Commission” means the Securities and Exchange Commission. 
  
 “Common Stock” means shares of the
Company’s common stock, par value $0.001 per share. 
  
 “Effectiveness Date” means (i) with respect to the initial Registration Statement required to be filed hereunder, a date no later than ninety (90) days following the date hereof and
(ii) with respect to each additional Registration Statement required to be filed hereunder, a date no later than forty (40) days following the applicable Filing Date. 
  
 “Effectiveness Period” has the meaning set forth in Section 2(a). 
  
 “Exchange Act” means the Securities
Exchange Act of 1934, as amended, and any successor statute. 
  
 “Filing Date” means, with respect to (i) the Registration Statement required to be filed hereunder in respect of the shares of Common Stock issuable upon conversion of the Note, a date no later
than thirty (30) days following the date hereof, (ii) the shares of Common Stock issuable upon exercise of any Warrant, the date which is thirty (30) days after the date of the issuance of such Warrant, and (iii) the shares of
Common Stock issuable to the Holder as a result of adjustments to the Fixed Conversion Price or Exercise Price, as the case may be, made pursuant to the Note or the Warrant or otherwise, thirty (30) days after the occurrence of such event or
the date of the adjustment of the Fixed Conversion Price or Exercise Price, as the case may be. 
  
 “Holder” or “Holders” means the Purchaser or any of its affiliates or transferees to the extent any of
them hold Registrable Securities, other than those purchasing Registrable Securities in a market transaction. 

 “Indemnified Party” has the meaning set forth in Section 5(c).

  
 “Indemnifying Party” has the
meaning set forth in Section 5(c). 
  
 “Note” has the meaning set forth in the Securities Purchase Agreement. 
  
 “Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation
or partial proceeding, such as a deposition), whether commenced or threatened. 
  
 “Prospectus” means the prospectus included in the Registration Statement (including, without limitation, a prospectus
that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated under the Securities Act), as amended or supplemented by any prospectus supplement, with
respect to the terms of the offering of any portion of the Registrable Securities covered by the Registration Statement, and all other amendments and supplements to the Prospectus, including post-effective amendments, and all material incorporated
by reference or deemed to be incorporated by reference in such Prospectus. 
  
 “Registrable Securities” means the shares of Common Stock issued upon the conversion of the Note and issuable upon exercise of the Warrants. 
  
 “Registration Statement” means each
registration statement required to be filed hereunder, including the Prospectus therein, amendments and supplements to such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material
incorporated by reference or deemed to be incorporated by reference in such registration statement. 
  
 “Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from
time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. 
  
 “Rule 415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from
time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. 
  
 “Securities Act” means the Securities Act of 1933, as amended, and any successor statute. 
  
 “Securities Purchase Agreement” has the
meaning given to such term in the Preamble hereto. 
  
 “Trading Market” means any of the NASD Over The Counter Bulletin Board, NASDAQ Capital Market, the NASDAQ National Market System, the American Stock Exchange or the New York Stock Exchange. 
  
 “Warrants” means the Common Stock purchase
warrants issued in connection with the Securities Purchase Agreement, whether on the date hereof or thereafter. 
  

 2 

 2. Registration. 
  
 (a) On or prior to the Filing Date the Company shall prepare and file with the Commission a Registration
Statement covering the Registrable Securities for a selling stockholder resale offering to be made on a continuous basis pursuant to Rule 415. The Registration Statement shall be on Form S-3 (except if the Company is not then eligible to register
for resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate form in accordance herewith). The Company shall cause each Registration Statement to become effective and remain effective as provided
herein. The Company shall use its reasonable commercial efforts to cause each Registration Statement to be declared effective under the Securities Act as promptly as possible after the filing thereof, but in any event no later than the Effectiveness
Date. The Company shall use its reasonable commercial efforts to keep each Registration Statement continuously effective under the Securities Act until the date which is the earlier date of when (i) all Registrable Securities have been sold or
(ii) all Registrable Securities covered by such Registration Statement may be sold immediately without registration under the Securities Act and without volume restrictions pursuant to Rule 144(k), as determined by the counsel to the Company
pursuant to a written opinion letter to such effect, addressed and acceptable to the Company’s transfer agent and the affected Holders (the “Effectiveness Period”). 
  
 (b) If: (i) any Registration Statement is not filed on or prior to the applicable Filing Date;
(ii) a Registration Statement filed hereunder is not declared effective by the Commission by the applicable Effectiveness Date; (iii) after a Registration Statement is filed with and declared effective by the Commission, a Discontinuation
Event (as hereafter defined) shall occur and be continuing, or such Registration Statement ceases to be effective (by suspension or otherwise) as to all Registrable Securities to which it is required to relate at any time prior to the expiration of
the Effectiveness Period (without being succeeded immediately by an additional registration statement filed and declared effective), for a period of time which shall exceed 45 days in the aggregate per year or more than 20 consecutive calendar days
(defined as a period of 365 days commencing on the date the Registration Statement is declared effective); or (iv) the Common Stock is not listed or quoted, or is suspended from trading on any Trading Market for a period of three
(3) consecutive Trading Days (in either case after the Company shall not have been able to cure such trading suspension within 30 days of the notice thereof or list the Common Stock on another Trading Market); (any such failure or breach being
referred to as an “Event,” and for purposes of clause (i) or (ii) the date on which such Event occurs, or for purposes of clause (iii) the date which such 45 day or 20 consecutive day period (as the case may be) is exceeded,
or for purposes of clause (iv) the date on which such three (3) Trading Day period is exceeded, being referred to as “Event Date”), then as partial relief for the damages to the Purchaser by reason of the occurrence of any such
Event (which remedy shall not be exclusive of any other remedies available at law or in equity), the Company shall pay to the Purchaser for each day that an Event has occurred and is continuing, an amount in cash as liquidated damages and not as a
penalty, equal to one-thirtieth (1/30th) of the product of: (A) the then outstanding principal amount of
the Note multiplied by (B) 0.02. In the event the Company fails to make any payments pursuant to 

  

 3 

 
this Section 2(b) in a timely manner, such payments shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in
full. 
  
 (c) Within three business days of the
Effectiveness Date, the Company shall cause its counsel to issue a blanket opinion in the form attached hereto as Exhibit A, to the transfer agent stating that the shares are subject to an effective registration statement and can be reissued free of
restrictive legend upon notice of a sale by the Purchaser and confirmation by the Purchaser that it has complied with the prospectus delivery requirements, provided that the Company has not advised the transfer agent orally or in writing that the
opinion has been withdrawn. Copies of the blanket opinion required by this Section 2(c) shall be delivered to the Purchaser within the time frame set forth above. 
  
 3. Registration Procedures. If and whenever the Company is required by the provisions hereof to effect the
registration of any Registrable Securities under the Securities Act, the Company will, as expeditiously as possible: 
  
 (a) prepare and file with the Commission a Registration Statement with respect to such Registrable Securities, respond as promptly as
possible to any comments received from the Commission, and use its reasonable commercial efforts to cause the Registration Statement to become and remain effective for the Effectiveness Period with respect thereto, and promptly provide to the
Purchaser copies of all filings and Commission letters of comment relating thereto; 
  
 (b) prepare and file with the Commission such amendments and supplements to the Registration Statement and the Prospectus used in
connection therewith as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all Registrable Securities covered by such Registration Statement and to keep such Registration Statement effective until
the expiration of the Effectiveness Period applicable to such Registration Statement; 
  
 (c) furnish to the Purchaser such number of copies of the Registration Statement and the Prospectus included therein (including each
preliminary Prospectus) as the Purchaser reasonably may request to facilitate the public sale or disposition of the Registrable Securities covered by the Registration Statement; 
  
 (d) use its commercially reasonable efforts to register or qualify the Purchaser’s Registrable
Securities covered by such Registration Statement under the securities or “blue sky” laws of such jurisdictions within the United States as the Purchaser may reasonably request, provided, however, that the Company shall not for any such
purpose be required to qualify generally to transact business as a foreign corporation in any jurisdiction where it is not so qualified or to consent to general service of process in any such jurisdiction; 
  
 (e) list the Registrable Securities covered by such
Registration Statement with any securities exchange on which the Common Stock of the Company is then listed; 
  
 (f) immediately notify the Purchaser at any time when a Prospectus relating thereto is required to be delivered under the Securities Act,
of the happening of any event 

  

 4 

 
of which the Company has knowledge as a result of which the Prospectus contained in such Registration Statement, as then in effect, includes an untrue
statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing; and 
  
 (g) make available for inspection by the Purchaser and any
attorney, accountant or other agent retained by the Purchaser, all publicly available, non-confidential financial and other records, pertinent corporate documents and properties of the Company, and cause the Company’s officers, directors and
employees to supply all publicly available, non-confidential information reasonably requested by the attorney, accountant or agent of the Purchaser. 
  
 4. Registration Expenses. All expenses relating to the Company’s compliance with Sections 2 and 3 hereof, including, without limitation, all
registration and filing fees, printing expenses, fees and disbursements of counsel and independent public accountants for the Company, fees and expenses (including reasonable counsel fees) incurred in connection with complying with state securities
or “blue sky” laws, fees of the NASD, transfer taxes, fees of transfer agents and registrars, fees of, and disbursements incurred by, one counsel for the Holders, are called “Registration Expenses”. All selling commissions
applicable to the sale of Registrable Securities, including any fees and disbursements of any special counsel to the Holders beyond those included in Registration Expenses, are called “Selling Expenses.” The Company shall only be
responsible for all Registration Expenses. 
  
 5.
Indemnification. 
  
 (a) In the event of a
registration of any Registrable Securities under the Securities Act pursuant to this Agreement, the Company will indemnify and hold harmless the Purchaser, and its officers, directors and each other person, if any, who controls the Purchaser within
the meaning of the Securities Act, against any losses, claims, damages or liabilities, joint or several, to which the Purchaser, or such persons may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or
liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in any Registration Statement under which such Registrable Securities were registered under
the Securities Act pursuant to this Agreement, any preliminary Prospectus or final Prospectus contained therein, or any amendment or supplement thereof, or arise out of or are based upon the omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse the Purchaser, and each such person for any reasonable legal or other expenses incurred by them in connection with investigating or
defending any such loss, claim, damage, liability or action; provided, however, that the Company will not be liable in any such case if and to the extent that any such loss, claim, damage or liability arises out of or is based upon an
untrue statement or alleged untrue statement or omission or alleged omission so made in conformity with information furnished by or on behalf of the Purchaser or any such person in writing specifically for use in any such document. 
  

 5 

 (b) In the event of a registration of the Registrable Securities under the Securities Act
pursuant to this Agreement, the Purchaser will indemnify and hold harmless the Company, and its officers, directors and each other person, if any, who controls the Company within the meaning of the Securities Act, against all losses, claims, damages
or liabilities, joint or several, to which the Company or such persons may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon
failure by the Purchaser to deliver an authorized Prospectus as required under law, use by the Purchaser of any unauthorized selling documents, or any untrue statement or alleged untrue statement of any material fact which was furnished in writing
by the Purchaser to the Company expressly for use in (and such information is contained in) the Registration Statement under which such Registrable Securities were registered under the Securities Act pursuant to this Agreement, any preliminary
Prospectus or final Prospectus contained therein, or any amendment or supplement thereof, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the
statements therein not misleading, and will reimburse the Company and each such person for any reasonable legal or other expenses incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action,
provided, however, that the Purchaser will be liable in any such case if and only to the extent that any such loss, claim, damage or liability arises out of or is based upon an untrue statement or alleged untrue statement or omission
or alleged omission so made in conformity with information furnished in writing to the Company by or on behalf of the Purchaser specifically for use in any such document. Notwithstanding the provisions of this paragraph, the Purchaser shall not be
required to indemnify any person or entity in excess of the amount of the aggregate net proceeds received by the Purchaser in respect of Registrable Securities in connection with any such registration under the Securities Act. 
  
 (c) Promptly after receipt by a party entitled to claim
indemnification hereunder (an “Indemnified Party”) of notice of the commencement of any action, such Indemnified Party shall, if a claim for indemnification in respect thereof is to be made against a party hereto obligated to indemnify
such Indemnified Party (an “Indemnifying Party”), notify the Indemnifying Party in writing thereof, but the omission so to notify the Indemnifying Party shall not relieve it from any liability which it may have to such Indemnified Party
other than under this Section 5(c) and shall only relieve it from any liability which it may have to such Indemnified Party under this Section 5(c) if and to the extent the Indemnifying Party is prejudiced by such omission. In case any
such action shall be brought against any Indemnified Party and it shall notify the Indemnifying Party of the commencement thereof, the Indemnifying Party shall be entitled to participate in and, to the extent it shall wish, to assume and undertake
the defense thereof with counsel satisfactory to such Indemnified Party, and, after notice from the Indemnifying Party to such Indemnified Party of its election so to assume and undertake the defense thereof, the Indemnifying Party shall not be
liable to such Indemnified Party under this Section 5(c) for any legal expenses subsequently incurred by such Indemnified Party in connection with the defense thereof; if the Indemnified Party retains its own counsel, then the Indemnified Party
shall pay all fees, costs and expenses of such counsel, provided, however, that, if the defendants in any such action include both the Indemnified Party and 

  

 6 

 
the Indemnifying Party and the Indemnified Party shall have reasonably concluded that there may be reasonable defenses available to it which are different
from or additional to those available to the Indemnifying Party or if the interests of the Indemnified Party reasonably may be deemed to conflict with the interests of the Indemnifying Party, the Indemnified Party shall have the right to select one
separate counsel and to assume such legal defenses and otherwise to participate in the defense of such action, with the reasonable expenses and fees of such separate counsel and other expenses related to such participation to be reimbursed by the
Indemnifying Party as incurred. 
  
 (d) In order
to provide for just and equitable contribution in the event of joint liability under the Securities Act in any case in which either (i) the Purchaser, or any officer, director or controlling person of the Purchaser, makes a claim for
indemnification pursuant to this Section 5 but it is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that
such indemnification may not be enforced in such case notwithstanding the fact that this Section 5 provides for indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of the Purchaser or
such officer, director or controlling person of the Purchaser in circumstances for which indemnification is provided under this Section 5; then, and in each such case, the Company and the Purchaser will contribute to the aggregate losses,
claims, damages or liabilities to which they may be subject (after contribution from others) in such proportion so that the Purchaser is responsible only for the portion represented by the percentage that the public offering price of its securities
offered by the Registration Statement bears to the public offering price of all securities offered by such Registration Statement, provided, however, that, in any such case, (A) the Purchaser will not be required to contribute any
amount in excess of the public offering price of all such securities offered by it pursuant to such Registration Statement; and (B) no person or entity guilty of fraudulent misrepresentation (within the meaning of Section 10(f) of the Act)
will be entitled to contribution from any person or entity who was not guilty of such fraudulent misrepresentation. 
  
 6. Representations and Warranties. 
  
 (a) The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and the Company has timely filed all proxy
statements, reports, schedules, forms, statements and other documents required to be filed by it under the Exchange Act. The Company has filed (i) its Annual Report on Form 10-K for its fiscal year ended December 31, 2004 and (ii) its
Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2005, June 30, 2005 and September 30, 2005 (collectively, the “SEC Reports”). Each SEC Report was, at the time of its filing, in substantial
compliance with the requirements of its respective form and none of the SEC Reports, nor the financial statements (and the notes thereto) included in the SEC Reports, as of their respective filing dates, contained any untrue statement of a material
fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC
Reports comply as to form in all material respects with applicable accounting requirements and the published rules and regulations 

  

 7 

 
of the Commission or other applicable rules and regulations with respect thereto. Such financial statements have been prepared in accordance with generally
accepted accounting principles (“GAAP”) applied on a consistent basis during the periods involved (except (i) as may be otherwise indicated in such financial statements or the notes thereto or (ii) in the case of unaudited
interim statements, to the extent they may not include footnotes or may be condensed and are subject to year-end adjustments) and fairly present in all material respects the financial condition, the results of operations and the cash flows of the
Company and its subsidiaries, on a consolidated basis, as of, and for, the periods presented in each such SEC Report. 
  
 (b) The Common Stock is listed for trading on the American Stock Exchange and satisfies all requirements for the continuation of such
listing, and the Company shall do all things necessary for the continuation of such listing. The Company has not received any notice that its Common Stock will be delisted from the American Stock Exchange (except for prior notices which have been
fully remedied) or that the Common Stock does not meet all requirements for the continuation of such listing. 
  
 (c) Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has directly or indirectly made any
offers or sales of any security or solicited any offers to buy any security under circumstances that would cause the offering of the Securities pursuant to the Securities Purchase Agreement to be integrated with prior offerings by the Company for
purposes of the Securities Act which would prevent the Company from selling the Common Stock pursuant to Rule 506 under the Securities Act, or any applicable exchange-related stockholder approval provisions, nor will the Company or any of its
affiliates or subsidiaries take any action or steps that would cause the offering of the Securities to be integrated with other offerings. 
  
 (d) The Warrants, the Note and the shares of Common Stock which the Purchaser may acquire pursuant to the Warrants and the Note are all
restricted securities under the Securities Act as of the date of this Agreement. The Company will not issue any stop transfer order or other order impeding the sale and delivery of any of the Registrable Securities at such time as such Registrable
Securities are registered for public sale or an exemption from registration is available, except as required by federal or state securities laws. 
  
 (e) The Company understands the nature of the Registrable Securities issuable upon the conversion of the Note and the exercise of the
Warrant and recognizes that the issuance of such Registrable Securities may have a potential dilutive effect. The Company specifically acknowledges that its obligation to issue the Registrable Securities is binding upon the Company and enforceable
regardless of the dilution such issuance may have on the ownership interests of other shareholders of the Company. 
  
 (f) Except for agreements made in the ordinary course of business, there is no agreement that has not been filed with the Commission as an
exhibit to a registration statement or to a form required to be filed by the Company under the Exchange Act, the breach of which could reasonably be expected to have a material and adverse effect on the Company and its subsidiaries, or would
prohibit or otherwise interfere with the ability of the Company to enter into and perform any of its obligations under this Agreement in any material respect. 
  

 8 

 (g) The Company will at all times have authorized and reserved a sufficient number of
shares of Common Stock for the full conversion of the Note and exercise of the Warrants. 
  
 7. Miscellaneous. 
  
 (a) Remedies. In the event of a breach by the Company or by a Holder, of any of their respective obligations under this Agreement, each Holder or the Company, as the case may be, in addition to being entitled
to exercise all rights granted by law and under this Agreement, including recovery of damages, will be entitled to specific performance of its rights under this Agreement. 
  
 (b) No Piggyback on Registrations. Except as and to the extent specified in Schedule 7(b) hereto,
neither the Company nor any of its security holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration Statement other than the Registrable Securities, and the Company shall not after
the date hereof enter into any agreement providing any such right for inclusion of shares in the Registration Statement to any of its security holders. Except as and to the extent specified in Schedule 7(b) hereto, the Company has not previously
entered into any agreement granting any registration rights with respect to any of its securities to any person or entity that have not been fully satisfied. 
  

(c) Compliance. Each Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities
Act as applicable to it in connection with sales of Registrable Securities pursuant to the Registration Statement. 
  
 (d) Discontinued Disposition. Each Holder agrees by its acquisition of such Registrable Securities that, upon receipt of a notice
from the Company of the occurrence of a Discontinuation Event (as defined below), such Holder will forthwith discontinue disposition of such Registrable Securities under the applicable Registration Statement until such Holder’s receipt of the
copies of the supplemented Prospectus and/or amended Registration Statement or until it is advised in writing (the “Advice”) by the Company that the use of the applicable Prospectus may be resumed, and, in either case, has received copies
of any additional or supplemental filings that are incorporated or deemed to be incorporated by reference in such Prospectus or Registration Statement. The Company may provide appropriate stop orders to enforce the provisions of this paragraph. For
purposes of this Agreement, a “Discontinuation Event” shall mean (i) when the Commission notifies the Company whether there will be a “review” of such Registration Statement and whenever the Commission comments in writing on
such Registration Statement (the Company shall provide true and complete copies thereof and all written responses thereto to each of the Holders); (ii) any request by the Commission or any other Federal or state governmental authority for
amendments or supplements to such Registration Statement or Prospectus or for additional information; (iii) the issuance by the Commission of any stop order suspending the effectiveness of such Registration 

  

 9 

 
Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose; (iv) the receipt by the Company of
any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose; and/or
(v) the occurrence of any event or passage of time that makes the financial statements included in such Registration Statement ineligible for inclusion therein or any statement made in such Registration Statement or Prospectus or any document
incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to such Registration Statement, Prospectus or other documents so that, in the case of such Registration Statement or
Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they
were made, not misleading. 
  
 (e) Piggy-Back
Registrations. If at any time during the Effectiveness Period there is not an effective Registration Statement covering all of the Registrable Securities and the Company shall determine to prepare and file with the Commission a registration
statement relating to an offering for its own account or the account of others under the Securities Act of any of its equity securities, other than on Form S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents
relating to equity securities to be issued solely in connection with any acquisition of any entity or business or equity securities issuable in connection with stock option or other employee benefit plans, then the Company shall send to each Holder
written notice of such determination and, if within fifteen (15) days after receipt of such notice, any such Holder shall so request in writing, the Company shall include in such registration statement all or any part of such Registrable
Securities such Holder requests to be registered to the extent the Company may do so without violating registration rights of others which exist as of the date of this Agreement, subject to customary underwriter cutbacks applicable to all holders of
registration rights and subject to obtaining any required consent of any selling stockholder(s) to such inclusion under such registration statement. 
  
 (f) Amendments and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended,
modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by the Company and the Holders of the then outstanding Registrable Securities.
Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of certain Holders and that does not directly or indirectly affect the rights of other Holders
may be given by Holders of at least a majority of the Registrable Securities to which such waiver or consent relates; provided, however, that the provisions of this sentence may not be amended, modified, or supplemented except in
accordance with the provisions of the immediately preceding sentence. 
  
 (g) Notices. Any notice or request hereunder may be given to the Company or the Purchaser at the respective addresses set forth below or as may hereafter be specified in a notice designated as a change of
address under this Section 7(g). Any 

  

 10 

 
notice or request hereunder shall be given by registered or certified mail, return receipt requested, hand delivery, overnight mail, Federal Express or other
national overnight next day carrier (collectively, “Courier”) or telecopy (confirmed by mail). Notices and requests shall be, in the case of those by hand delivery, deemed to have been given when delivered to any party to whom it is
addressed, in the case of those by mail or overnight mail, deemed to have been given three (3) business days after the date when deposited in the mail or with the overnight mail carrier, in the case of a Courier, the next business day following
timely delivery of the package with the Courier, and, in the case of a telecopy, when confirmed. The address for such notices and communications shall be as follows: 
  

					
	If to the Company:	  	Path 1 Network Technologies Inc.
	 	  	6215 Ferris Square, Suite 140
	 	  	San Diego, California 92121
	 	  	Attention:	 	Chief Financial Officer
	 	  	Facsimile:	 	858-450-4203
		
	 	  	with a copy to:
	 	  	Heller Ehrman LLP
	 	  	4350 La Jolla Village Drive, 7th
Floor
	 	  	San Diego, CA 92122
	 	  	Attention:	 	Hayden Trubitt, Esq.
	 	  	Facsimile:	 	858-587-5903
		
	If to a Purchaser:	  	To the address set forth under such Purchaser name on the signature pages hereto.
		
	If to any other Person who is then the registered Holder:	  	To the address of such Holder as it appears in the stock transfer books of the Company

  
 or such other address
as may be designated in writing hereafter in accordance with this Section 7(g) by such Person. 
  
 (h) Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns
of each of the parties and shall inure to the benefit of each Holder. The Company may not assign its rights or obligations hereunder without the prior written consent of each Holder. Each Holder may assign their respective rights hereunder in the
manner and to the persons and entities as permitted under the Note and the Securities Purchase Agreement. 
  
 (i) Execution and Counterparts. This Agreement may be executed in any number of counterparts, each of which when so executed shall
be deemed to be an original and, all of which taken together shall constitute one and the same agreement. In the event that any signature is delivered by facsimile transmission, such signature shall create a valid binding obligation of the party
executing (or on whose behalf such signature is executed) the same with the same force and effect as if such facsimile signature were the original thereof. 
  

 11 

 (j) Governing Law, Jurisdiction and Waiver of Jury Trial. THIS AGREEMENT SHALL BE
GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS MADE AND PERFORMED IN SUCH STATE, WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW. The Company hereby consents and agrees that the
state or federal courts located in the County of New York, State of New York shall have exclusion jurisdiction to hear and determine any Proceeding between the Company, on the one hand, and the Purchaser, on the other hand, pertaining to this
Agreement or to any matter arising out of or related to this Agreement; provided, that the Purchaser and the Company acknowledge that any appeals from those courts may have to be heard by a court located outside of the County of New York,
State of New York, and further provided, that nothing in this Agreement shall be deemed or operate to preclude the Purchaser from bringing a Proceeding in any other jurisdiction to collect the obligations, to realize on the Collateral
or any other security for the obligations, or to enforce a judgment or other court order in favor of the Purchaser. The Company expressly submits and consents in advance to such jurisdiction in any Proceeding commenced in any such (County of New
York) court, and the Company hereby waives any objection which it may have based upon lack of personal jurisdiction, improper venue or forum non conveniens. The Company hereby waives personal service of the summons, complaint and other
process issued in any such Proceeding and agrees that service of such summons, complaint and other process may be made by registered or certified mail addressed to the Company at the address set forth in Section 7(g) and that service so made
shall be deemed completed upon the earlier of the Company’s actual receipt thereof or five (5) days after deposit in the U.S. mails, proper postage prepaid. The parties hereto desire that their disputes be resolved by a judge applying such
applicable laws. Therefore, to achieve the best combination of the benefits of the judicial system and of arbitration, the parties hereto waive all rights to trial by jury in any Proceeding brought to resolve any dispute, whether arising in
contract, tort, or otherwise between the Purchaser and/or the Company arising out of, connected with, related or incidental to the relationship established between then in connection with this Agreement. If either party hereto shall commence a
Proceeding to enforce any provisions of this Agreement, the Securities Purchase Agreement or any other Related Agreement, then the prevailing party in such Proceeding shall be reimbursed by the other party for its reasonable attorneys’ fees and
other costs and expenses incurred with the investigation, preparation and prosecution of such Proceeding. 
  
 (k) Cumulative Remedies. The remedies provided herein are cumulative and not exclusive of any remedies provided by law. 

 
 (l) Severability. If any term, provision, covenant
or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect
and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their reasonable efforts to find and employ an 

  

 12 

 
alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby
stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
unenforceable. 
  
 (m) Headings. The
headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. 
  
 [Balance of page intentionally left blank; signature page follows] 
  

 13 

 IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first
written above. 
  

									
	PATH 1 NETWORK TECHNOLOGIES INC.	 	 	 	LAURUS MASTER FUND, LTD.
					
	By:	 	/s/ Jeremy Ferrell	 	 	 	By:	 	/s/ Eugene Grin
					
	Name: 	 	Jeremy Ferrell	 	 	 	Name: 	 	Eugene Grin
					
	Title: 	 	Interim CFO	 	 	 	Title: 	 	Fund Manager
	 	 	 	 	 	 	  
 Address for Notices:
  
 825 Third Avenue, 14th Floor
 New York, NY 10022
 Attention:     David Grin
 Facsimile:
     212-541-4434

  

 14 

 EXHIBIT A 
  

			
	                    , 200  	  	 Hayden J. Trubitt
 Hayden.Trubitt@hellerehrman.com
 Direct +1.858.450.5754
 Direct Fax +1.858.587.5903
 Main +1.858.450.8400
 Fax +1.858.450.8499
  
 39844.0001

  
 Registrar and Transfer Company

 10 Commerce Drive 
 Cranford, NJ 07016-3572 
 Attn: Daniel M. Flynn 
  

	 	Re:	Path 1 Network Technologies Inc. Registration Statement on Form S-3 

  
 Ladies and Gentlemen: 
  
 As counsel to Path 1 Network Technologies Inc., a Delaware corporation (the “Company”), we have been requested to render our opinion to you in
connection with the issuance by the Company to transferees of Laurus Master Fund, Ltd., of an aggregate of up to _________ shares (the “Shares”) of the Company’s Common Stock upon conversion of principal of and/or interest on a
Secured Convertible Term Note dated December 6, 2005 or exercise of a Warrant dated December 6, 2005. Such transferees will be respectively identified to you from time to time, by Laurus, before issuance of each respective tranche of
Shares. 
  
 A Registration Statement on Form S-3 under the
Securities Act of 1933, as amended (the “Act”), with respect to the resale of the Shares was declared effective by the Securities and Exchange Commission on [date]. Enclosed is the Prospectus dated [date]. Laurus has agreed for the benefit
of the Company that it would offer and sell the Shares in the manner described in the Prospectus and that the Prospectus would be duly delivered in connection with any sale. 
  
 Based upon the foregoing, upon request by Laurus at any time while the registration statement remains effective in the
situation where Shares are to be issued initially to Laurus’ transferees in respect of a sale by Laurus which occurred before the conversion or exercise, it is our opinion that the Shares have been registered for resale under the Act and new
certificates evidencing the Shares may be issued directly to such transferees without restrictive legend. We or the Company will advise you if the registration statement is not available or effective at any point in the future. 
  

	
	Very truly yours,
	
	 /s/ Hayden J. Trubitt

	Hayden J. Trubitt

 SCHEDULE 7(b)Representative form Stock Option Agreement

 Exhibit 10.4 
  
 STOCK OPTION AGREEMENT 
  
 This Stock Option Agreement (this “Agreement”) is made as of this 18th day of May, 2005 by and between ADE Corporation, a Massachusetts
corporation (the “Company”), and Landon T. Clay (the “Optionee”). 
  
 WITNESSETH THAT: 
  
 WHEREAS, the Board of Directors of the Company (the “Board”) has granted to the Optionee a stock option upon the terms and subject to the conditions of this Agreement; and 
  
 WHEREAS, the Board has designated this stock option a non-qualified stock
option. 
  
 NOW, THEREFORE, in consideration of the premises and
the mutual covenants and agreements herein contained, the Company and the Optionee agree as follows: 
  
 1. Definitions. Unless otherwise specified or unless the context otherwise requires, the following terms, as used in this Agreement, shall have the following meanings: 
  
 “Code” means the United States Internal Revenue Code of
1986, as amended from time to time. 
  
 “Committee” means the Compensation Committee of the Board or any successor thereto appointed by the Board, or in the absence of any such Committee, means the full Board. 
  
 “Disability” or “Disabled” means permanent
or total disability as defined in Section 22(e)(3) of the Code. 
  
 “Securities Act” means the Securities Act of 1933, as amended from time to time. 
  
 “Fair Market Value” means, with respect to a share of Common Stock on a particular date, the mean between the highest and lowest quoted
selling prices on such date (the “valuation date”) on the securities market where the Common Stock of the Company is traded, or if there were no sales on the valuation date, on the next preceding date within a reasonable period (as
determined in the sole discretion of the Committee) on which there were sales. In the event that there were no sales in such a market within a reasonable period, or in the event the Common Stock of the Company is not traded on any securities market,
the Fair Market Value shall be as determined in good faith by the Committee in its sole discretion. 
  
 “Survivors” means, in the event of the Optionee’s death, the Optionee’s legal representatives and/or any person or persons who
acquired the Optionee’s rights to the Option by will or by the laws of descent or distribution. 
  
 2. Grant. Subject to the terms and conditions of this Agreement, the Company may grant to the Optionee, from time to time, the option (each, an “Option”) to purchase from the Company, from time
to time, the number of shares (the “Shares”) of Common Stock, $.01 par value per share (the “Common Stock”), of the Company, as determined by the Committee and specified in one or more schedules to be delivered to
the Optionee in the form attached hereto as Exhibit A (the “Schedule”). 

 3. Exercise Price and Further Conditions. The exercise price per share of each Option shall be the Fair Market
Value of the Shares on the date of grant and shall be set forth in each Schedule, subject to adjustment as provided herein. 
  
 4. Term and Exercisability of Option. The Option shall expire on the expiration date specified in each Schedule and shall be exercisable in accordance with and
subject to the conditions set forth in Sections 5, 6, 7 and 8 of this Agreement and those conditions, if any, set forth in each Schedule. 
  
 5. Termination of Service. 
  
 (a) Except as otherwise provided in Sections 6, 7 or 8 of this Agreement, if the Optionee ceases to be a Director of the Company (a
“Cessation”) for any reason other than removal “for cause”, Disability or death before the Optionee has exercised the Option in full, the Optionee may exercise the Option to the extent that the Option is exercisable on the
date of the Optionee’s Cessation, but only within a period of not more than three (3) months after the date of such Cessation or, if earlier, within the originally prescribed term of the Option. 
  
 (b) The provisions of this Section 5, and not the provisions of
Section 7 or 8 of this Agreement, shall apply if the Optionee subsequently becomes disabled or dies after Cessation; provided, however, that in the case of the Optionee’s death within three (3) months after Cessation, the
Optionee’s Survivors may exercise the Option within one (1) year after the date of the Optionee’s death, but in no event after the date of expiration of the term of the Option. 
  
 (c) Notwithstanding anything herein to the contrary, if subsequent to the
Optionee’s Cessation, but prior to the exercise of the Option, the Committee determines that, either prior or subsequent to such Cessation, the Optionee engaged in conduct which would constitute “cause” (as defined in Section 6
of this Agreement), then the Optionee shall forthwith cease to have any right to exercise the Option. 
  
 6. Removal for Cause. In the event the Optionee is removed from office “for cause,” all outstanding and unexercised Options as of the date the Optionee is notified of his or her removal from office
“for cause” will immediately be forfeited. For purposes of this Section 6, “cause” shall include (and is not limited to) dishonesty with respect to the Company, insubordination, substantial malfeasance or nonfeasance of
duty, unauthorized disclosure of confidential information and conduct substantially prejudicial to the business of the Company. The determination of the Committee as to the existence of cause will be conclusive on the Optionee and the Company.
“Cause” is not limited to events which have occurred prior to the Optionee’s removal, nor is it necessary that the Committee’s finding of “cause” occur prior to removal. If the Committee determines, subsequent to the
Optionee’s removal but prior to the exercise of the Option, that either prior or subsequent to the Optionee’s removal the Optionee engaged in conduct which would constitute “cause,” then the right to exercise the Option shall be
forfeited. Any definition in an agreement between the Optionee and the Company which contains a conflicting definition of “cause” for removal and which is in effect at the time of such removal shall supersede the definition in this
Agreement with respect to the Optionee. 
  

 - 2 - 

 7. Cessation for Disability. 
  
 (a) In the event of Cessation by reason of a Disability, the Optionee may exercise the Option granted to him or to her to
the extent exercisable but not exercised on the date of the Disability. The Optionee may exercise the Option only within a period of not more than one (1) year after the date that the Optionee became Disabled or, if earlier, within the
originally prescribed term of the Option. 
  
 (b) The Committee
shall make the determination both of whether a Disability has occurred and the date of its occurrence (unless a procedure for such determination is set forth in another agreement between the Company and the Optionee, in which case such procedure
shall be used for such determination). If requested, the Optionee shall be examined by a physician selected or approved by the Committee, the cost of which examination shall be paid for by the Company. 
  
 8. Death While a Director. In the event of the death of the Optionee while he or she
is a Director of the Company, the Option may be exercised by the Optionee’s Survivors to the extent exercisable but not exercised on the date of death. The Option must be exercised within one (1) year after the date of death of the
Optionee. 
  
 9. Method of Exercise. 
  
 (a) The Option (or any part or installment thereof) shall be exercised by
giving written notice to the Company, together with provision for payment of the full purchase price in accordance with this Section 9 for the Shares, and upon compliance with any other conditions set forth in this Agreement. Such written
notice shall be signed by the Optionee, shall state the number of Shares which are being exercised and shall contain any representation required by this Agreement. 
  
 (b) Payment of the purchase price for the Shares shall be made (i) in United States dollars in cash or by check,
(ii) through delivery of shares of Common Stock already owned by the Optionee not subject to any restriction under any plan and having a Fair Market Value equal as of the date of exercise to the cash exercise price of the Option, (iii) at
the discretion of the Committee, by any other means, including a promissory note of the Optionee, which the Committee determines to be consistent with the purpose of this Agreement and applicable law, (iv) at the discretion of the Committee, in
accordance with a cashless exercise program established with a securities brokerage firm and approved by the Committee or (v) at the discretion of the Committee, by any combination of (i), (ii), (iii) and (iv) above. 
  
 (c) The Company shall reasonably promptly deliver the Shares to the Optionee
(or to the Optionee’s Survivors, as the case may be). In determining what constitutes “reasonably promptly,” it is expressly understood that the delivery of the Shares may be delayed by the Company in order to comply with any law or
regulation which requires the Company to take any action with respect to the Shares prior to their issuance. The Shares shall, upon delivery, be fully paid, non-assessable Shares. 
  
 10. Nonassignability of the Option. The Option shall not be transferable by the Optionee other than by will or by the laws of descent
and distribution; provided, however, that the designation of a beneficiary of the Option by the Optionee shall not be deemed a transfer 

  

 - 3 - 

 
prohibited by this Section 10. The Option shall be exercisable, during the Optionee’s lifetime, only by the Optionee (or by his or her legal
representative) and shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be subject to execution, attachment or similar process. Any attempted transfer, assignment, pledge, hypothecation
or other disposition of the Option or of any rights granted hereunder contrary to the provisions of this Section 10, or the levy of any attachment or similar process upon the Option, shall be null and void. 
  
 11. Purchase for Investment. Unless the offering and sale of the Shares to be issued
upon the exercise of the Option shall have been effectively registered under the Securities Act, the Company shall be under no obligation to issue the Shares covered by such exercise unless and until the following conditions have been fulfilled:

  
 (a) The Optionee shall warrant to the Company, at the time of
such exercise or receipt, as the case may be, that he or she is acquiring the Shares for his or her own account for investment and not with a view to, or for sale in connection with, the distribution of any such Shares, in which event the Optionee
shall be bound by the provisions of the following legend which shall be endorsed upon the certificate evidencing the Shares issued pursuant to such exercise or such grant: 
  
 “The shares represented by this certificate have been taken for investment and they may not be sold or otherwise
transferred by any person, including a pledgee, unless (1) either (a) a Registration Statement with respect to such shares shall be effective under the Securities Act of 1933, as amended, or (b) the Company shall have received an
opinion of counsel satisfactory to it that an exemption from registration under such Act is then available, and (2) there shall have been compliance with all applicable state securities laws. 
  
 (b) The Company shall have received an opinion of its counsel that the Shares
may be issued upon such exercise in compliance with the Securities Act without registration thereunder. 
  
 The Company may delay issuance of the Shares until completion of any action or obtaining any consent which the Company deems necessary under any applicable law (including, without limitation, state securities or
“blue sky” laws). 
  
 12. Adjustments. Upon the occurrence of any
of the following events, the Optionee’s rights with respect to the Option granted to him or her hereunder which has not previously been exercised in full shall be adjusted as hereinafter provided: 
  
 (a) Stock Dividends and Stock Splits. If the shares of Common Stock
shall be subdivided or combined into a greater or smaller number of shares or if the Company shall issue any shares of Common Stock as a stock dividend on its outstanding Common Stock, the number of Shares deliverable upon the exercise of the Option
shall be appropriately increased or decreased proportionately, and appropriate adjustments shall be made in the purchase price per share to reflect such subdivision, combination or stock dividend. 
  
 (b) Mergers and Consolidations. If the Company is to be consolidated
with or acquired by another entity in a merger, or in the event of a sale of all or substantially all of the Company’s assets (an “Acquisition”), the Company may take such action with respect to the 

  

 - 4 - 

 
Option as the Committee or the Board may deem to be equitable and in the best interests of the Company and the Optionee under the circumstances, including,
without limitation, (i) giving the Optionee reasonable advance notice of the pendency of the Acquisition and accelerating the vesting of the Option so that it becomes exercisable in full immediately prior to the Acquisition, (ii) making
appropriate provision for the continuation of the Option by substituting on an equitable basis for the Shares then subject to the Option either the consideration payable with respect to the outstanding shares of Common Stock in connection with the
Acquisition or securities of any successor or acquiring entity or (iii) giving the Optionee reasonable advance notice of the pendency of the Acquisition and canceling the Option effective upon the Acquisition if it is not exercised prior to the
Acquisition. 
  
 (c) Recapitalization or Reorganization. In
the event of a recapitalization or reorganization of the Company (other than a transaction described in paragraph (b) of this Section 12) pursuant to which securities of the Company or of another corporation are issued with respect to the
outstanding shares of Common Stock, the Optionee upon exercising the Option shall be entitled to receive for the purchase price paid upon such exercise the securities he or she would have received if he or she had exercised the Option prior to such
recapitalization or reorganization. 
  
 13. Fractional Shares. No
fractional share shall be issued under this Agreement, and the Optionee shall receive from the Company cash in lieu of any such fractional share equal to the Fair Market Value thereof determined in good faith by the Board of the Company. 

 
 14. Rights as Shareholder. The Optionee shall have no rights as a shareholder with
respect to any Shares or other securities covered by the Option, except after due exercise thereof and tender of the full purchase price for the Shares being purchased pursuant to such exercise, and registration of the Shares in the Company’s
share register in the name of the Optionee. 
  
 15. General Provisions.

  
 (a) Amendment; Waivers. This Agreement contains the
full and complete understanding and agreement of the parties hereto as to the subject matter hereof and, except as otherwise permitted by the express terms of this Agreement, it may not be modified or amended, nor may any provision hereof be waived,
except by a further written agreement duly signed by each of the parties. The waiver by either of the parties hereto of any provision hereof in any instance shall not operate as a waiver of any other provision hereof or in any other instance.

  
 (b) Binding Effect. This Agreement shall inure to the
benefit of and be binding upon the parties hereto and, to the extent provided herein, their respective heirs, executors, administrators, representatives, successors and assigns. 
  
 (c) Construction. The titles of the sections of this Agreement are included for convenience only and shall not be
construed as modifying or affecting their provisions. The masculine gender shall include both sexes; the singular shall include the plural and the plural the singular unless the context otherwise requires. 
  
 (d) Governing Law. This Agreement shall be governed by and construed
and enforced in accordance with the applicable laws of The Commonwealth of Massachusetts (other 

  

 - 5 - 

 
than the law governing conflict of law questions) except to the extent the laws of any other jurisdiction are mandatorily applicable. 
  
 (e) Notices. Any notice in connection with this Agreement shall be
deemed to have been properly delivered if it is in writing and is delivered by hand or facsimile or sent by registered mail to the party addressed as follows, unless another address has been substituted by notice so given: 
  

			
	 To the Optionee:
	  	 To his or her address as listed on the books of the Company.

		
	 To the Company:
	  	 ADE Corporation

	 	  	 80 Wilson Way

	 	  	 Westwood, Massachusetts 02090-1806

	 	  	 Attention: Brian James

  
 IN WITNESS WHEREOF,
the Optionee has executed this Agreement and the Company has caused this Stock Option Agreement to be executed by its officer thereunto duly authorized, all as of the date first set forth above. 
  

	
	 ADE Corporation

	
	 /s/ Brian C. James

	 Title: Treasurer and CFO

	
	 /s/ Landon T. Clay

	 (Signature of Optionee)

  

 - 6 - 

 Exhibit A 
  
 ADE CORPORATION 
 SCHEDULE EVIDENCING GRANTING OF STOCK OPTION AND 
 ACKNOWLEDGMENT OF RECEIPT 
  

			
	 Granted to:
	  	 
		
	 Grant Date:
	  	 Options Granted:

		
	 Expiration Date:
	  	 Exercise Price per Share:

  
 Vesting Schedule

  

															
	 Shares

	  	Vest On

	  	Shares

	  	Vest On

	  	Shares

	  	Vest On

	  	Shares

	  	Vest On

	 	  	 	  	 	  	 	  	 	  	 	  	 	  	 
	 	  	 	  	 	  	 	  	 	  	 	  	 	  	 
	 	  	 	  	 	  	 	  	 	  	 	  	 	  	 
	 	  	 	  	 	  	 	  	 	  	 	  	 	  	 
	 	  	 	  	 	  	 	  	 	  	 	  	 	  	 

  
 ADE Corporation (the
“Company”) hereby grants to the Optionee named above, as of the date set forth above, an option (the “Option”) pursuant to that certain Stock Option Agreement, dated as of May 18, 2005 (the
“Agreement”) to purchase the number of shares of the Company’s Common Stock, $.01 par value, at the exercise price and in accordance with the vesting schedule set forth above. 
  
 The Optionee hereby acknowledges receipt of the Option in accordance with the
terms set forth above. The Optionee further acknowledges that the Option is subject to the terms and conditions of this Schedule and the Agreement. 
  
 Without limiting the generality of the foregoing, the Optionee understands and agrees that: 
  
 (a) The Option is not transferable by the Optionee otherwise than by operation of law and is exercisable, during the
Optionee’s lifetime, only by him or her. 
  
 (b) To the
extent that any shares of the Company’s Common Stock, owned by the Optionee and delivered in payment of the exercise price as provided in the Agreement, were acquired by the Optionee from the Company, said shares shall have been owned by the
Optionee for at least six months prior to the date of such delivery. 

 At any time when the Optionee wishes to exercise the Option, in whole or in part, the Optionee shall
submit a duly executed Notice of Exercise of Option to the Company. Copies of such notice are available from the Company. 
  

							
	 ADE Corporation
	 	 	 	 Optionee

				
	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 (Signature)

				
	Title:	 	 	 	 	 	 
	 	 	 	 	 	 	 (Name)

				
	Date:	 	 	 	 	 	 
	 	 	 	 	 	 	 (Date)

  
 Please Return To:

 Chris Gallagher 
 Investor
Relations 
 ADE Corporation 
 80
Wilson Way 
 Westwood, MA 02090 

  
 Schedule to Exhibit 10.4

  
 The following non-employee Directors are parties to Stock
Option Agreements with the Company which are substantially identical in all material respects to the representative Stock Option Agreement filed herewith and are dated as of the respective dates listed below. The other Stock Option Agreements
are omitted pursuant to Instruction 2 to Item 601 of Regulation S-K. 
  

			
	 Name of Signatory

	  	 Date

	 Harris Clay
	  	 May 18, 2005

	 H. Kimball Faulkner
	  	 May 18, 2005

	 Kendall Wright
	  	 May 18, 2005

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00094-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00094-of-00352.parquet"}]]